tiprankstipranks
Trending News
More News >
Milestone Pharmaceuticals (MIST)
NASDAQ:MIST
US Market

Milestone Pharmaceuticals (MIST) Income Statement

Compare
778 Followers

Milestone Pharmaceuticals Income Statement

Last quarter (Q4 2025), Milestone Pharmaceuticals's total revenue was $1.44M, an increase of Infinity% from the same quarter last year. In Q4, Milestone Pharmaceuticals's net income was $-33.73M. See Milestone Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.55M$ 0.00$ 1.00M$ 5.00M$ 15.00M
Gross Profit
$ 0.00$ 0.00$ 1.00M$ 5.00M$ 15.00M
Operating Expenses
$ 35.38M$ 42.10M$ 62.10M$ 64.64M$ 58.07M
Depreciation and Amortization
$ 0.00$ 105.00K$ 92.00K$ 89.00K$ 93.00K
EBITDA
$ -62.14M$ -37.83M$ -57.04M$ -58.30M$ -42.98M
Operating Income
$ -62.14M$ -42.10M$ -61.10M$ -59.64M$ -43.07M
Other Income/Expenses
$ 0.00$ 583.00K$ 1.41M$ 1.25M$ 220.00K
Pretax Income
$ 0.00$ -41.52M$ -59.69M$ -58.39M$ -42.85M
Net Income
$ 0.00$ -41.52M$ -59.69M$ -58.39M$ -42.85M
Per Share Metrics
Basic EPS
$ -0.75$ -0.67$ -1.39$ -1.35$ -1.02
Diluted EPS
$ -0.75$ -0.67$ -1.39$ -1.35$ -1.02
Weighted Average Shares Outstanding
83.88M 62.21M 42.96M 42.45M 41.83M
Weighted Average Shares Outstanding (Diluted)
83.88M 62.21M 42.96M 42.45M 41.83M
Currency in USD

Milestone Pharmaceuticals Earnings and Revenue History